Candesartan Cilexetil CAS 145040-37-5 Purity > 99.0% (HPLC) API Hoobkas
Ruifu Chemical Supply Candesartan Cilexetil Intermediate Nrog Siab Purity
Candesartan Cilexethyl CAS 145040-37-5
Candesartan CAS 139481-59-7
1-Chloroethyl Cyclohexyl Carbonate CAS 99464-83-2
Candesartan Cilexetil Intermediate Eethyl Ester C6 CAS 139481-41-7
Candesartan Cilexetil Intermediate CAS 139481-44-0
Trityl Candesartan Cileexetil CAS 170791-09-0
Tshuaj npe | Candesartan Cilexeth |
Synonyms | TCV-116;1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-(((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H benzo[d]imidazole-7-Carboxylate |
CAS Nr | 145040-37-5 |
CAT Number | Qauv: RF-PI1891 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C33H34N6O6 |
Molecular Luj | 610.66 ib |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb rau Off-White Crystalline Hmoov |
Kev txheeb xyuas HPLC | Lub sijhawm khaws cia ntawm lub ncov loj hauv chromatogram ntawm tus qauv sib raug rau qhov hauv chromatogram tau nrog tus qauv |
Identification IR | IR infrared absorption spectrum yog zoo ib yam li Candesartan Cilexetil siv tus qauv |
Clarity thiab xim daws | Cov tshuaj hauv chloroform ntawm 5% yog ntshiab thiab tsis muaj xim |
Purity / Analysis Method | > 99.0% (HPLC) |
Melting Point | 155.0 ~ 160.0 ℃ |
Poob rau ziab | <0.30% |
Residue ntawm Ignition | <0.10% |
Hnyav Hlau | <10ppm |
Arsenic (As) | <1 ppm |
Particle Loj Distribution | 90% <30μm |
Organic impurities | los ntawm HPLC |
Ethyl Candesartan | <0.15% |
Desethyl Candesartan | <0.15% |
N2-Ethyl Candesartan Cilexei | <0.15% |
Tej yam tsis paub impurity | <0.15% |
Tag nrho cov impurities | <0.60% |
Kev ntsuam xyuas los ntawm Potentiometry | 99.0 ~ 101.0% ntawm C33H34N6O6, xam rau ntawm cov khoom tsis muaj dej |
Organic Volatile impurity | |
Methano | <0.30% |
Ethanol | <0.50% |
Diethyl Ether | <0.50% |
Aceton | <0.50% |
Dichloromethan | <0.06% |
Dimethylformamide | <0.088% |
Microbiological Contarination | |
Tag nrho Aerobic Microbial suav | <1000cfu/g |
Moulds & Poov xab | <100cfu/g |
E. Coli | Tsis muaj |
Salmonella | Tsis muaj |
Test Standard | Enterprise Standard |
Kev siv | API;Antihypertensive Agent |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo
Candesartan Cilexetil (TCV-116) (CAS: 145040-37-5) yog angiotensin II receptor antagonist nrog IC50 ntawm 0.26 nM, siv rau kev kho mob ntshav siab.Candesartan yog ib qho angiotensin-receptor blocker (ARB) uas yuav siv tau ib leeg lossis nrog lwm tus neeg ua haujlwm los kho ntshav siab.Nws yog siv nyob rau hauv qhov ncauj raws li prodrug, candesartan cilexetil, uas yog sai hloov mus rau nws active metabolite, candesartan, thaum nqus nyob rau hauv lub plab hnyuv ib ntsuj av.Candesartan txo cov ntshav siab los ntawm antagonizing renin-angiotensin-aldosterone system (RAAS);Nws sib tw nrog angiotensin II rau kev khi rau hom-1 angiotensin II receptor (AT1) subtype thiab tiv thaiv cov ntshav siab nce los ntawm angiotensin II.Tsis zoo li angiotensin-hloov enzyme (ACE) inhibitors, ARBs tsis muaj qhov tsis zoo ntawm hnoos qhuav.Candesartan tuaj yeem siv los kho cov ntshav siab, cais tawm systolic hypertension, sab laug ventricular hypertrophy thiab ntshav qab zib nephropathy.Nws kuj tseem siv tau los ua lwm tus neeg sawv cev rau kev kho mob plawv tsis ua haujlwm, systolic tsis ua haujlwm, myocardial infarction thiab kab mob plawv.